Holly M. Biggs

Holly M. Biggs

Auto-generated profile, based on publicly available information

Holly M. Biggs

Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention , Atlanta, Georgia

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Emerging Infectious Diseases
Verified
Journal Article
Open access
HBHolly M. Biggs
Holly M. Biggs
XLXiaoyan Lu
Xiaoyan Lu
LDLisa Dettinger
Lisa Dettinger
SSSenthilkumar Sakthivel
Senthilkumar Sakthivel
JWJohn T. Watson
John T. Watson
SBSameh W. Boktor
Sameh W. Boktor
Adenovirus-Associated Influenza-Like Illness among College Students, Pennsylvania, USA

1 May 2016 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
Abdullah M. AsiriAbdullah M. Asiri
Abdullah M. Asiri
HBHolly M. Biggs
Holly M. Biggs
GAGlen R. Abedi
Glen R. Abedi
XLXiaoyan Lu
Xiaoyan Lu
ASAbdulaziz Bin Saeed
Abdulaziz Bin Saeed
JWJohn T. Watson
John T. Watson
During July–August 2015, the number of cases of Middle East respiratory syndrome (MERS) reported from Saudi Arabia increased dramatically. We reviewed the 143 confirmed cases from this period and classified each based upon likely transmission source. We found that the surge in cases resulted predominantly (90%) from secondary transmission largely attributable to an outbreak at a single healthcare facility in Riyadh. Genome sequencing of MERS coronavirus from 6 cases demonstrated continued circulation of the recently described recombinant virus. A single unique frameshift deletion in open reading frame 5 was detected in the viral sequence from 1 case.

31 December 2018 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Open access
PDF file
KAKhalid H. Alanazi
Khalid H. Alanazi
MKMarie E. Killerby
Marie E. Killerby
HBHolly M. Biggs
Holly M. Biggs
GAGlen R. Abedi
Glen R. Abedi
HJHani Jokhdar
Hani Jokhdar
JWJohn T. Watson
John T. Watson
Objective: To investigate a Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak event involving multiple healthcare facilities in Riyadh, Saudi Arabia; to characterize transmission; and to explore infection control implications.Design: Outbreak investigation.Setting: Cases presented in 4 healthcare facilities in Riyadh, Saudi Arabia: a tertiary-care hospital, a specialty pulmonary hospital, an outpatient clinic, and an outpatient dialysis unit.Methods: Contact tracing and testing were performed following reports of cases at 2 hospitals. Laboratory results were confirmed by real-time reverse transcription polymerase chain reaction (rRT-PCR) and/or genome sequencing. We assessed exposures and determined seropositivity among available healthcare personnel (HCP) cases and HCP contacts of cases.Results: In total, 48 cases were identified, involving patients, HCP, and family members across 2 hospitals, an outpatient clinic, and a dialysis clinic. At each hospital, transmission was linked to a unique index case. Moreover, 4 cases were associated with superspreading events (any interaction where a case patient transmitted to ≥5 subsequent case patients). All 4 of these patients were severely ill, were initially not recognized as MERS-CoV cases, and subsequently died. Genomic sequences clustered separately, suggesting 2 distinct outbreaks. Overall, 4 (24%) of 17 HCP cases and 3 (3%) of 114 HCP contacts of cases were seropositive.Conclusions: We describe 2 distinct healthcare-associated outbreaks, each initiated by a unique index case and characterized by multiple superspreading events. Delays in recognition and in subsequent implementation of control measures contributed to secondary transmission. Prompt contact tracing, repeated testing, HCP furloughing, and implementation of recommended transmission-based precautions for suspected cases ultimately halted transmission.

12 May 2025 in Open Forum Infectious Diseases
Verified
Journal Article
Closed access
HBHolly M Biggs
Holly M Biggs
RLRongxia Li
Rongxia Li
KJKelly A Jackson
Kelly A Jackson
JNJoelle Nadle
Joelle Nadle
SPSusan Petit
Susan Petit
ISIsaac See
Isaac See
Background: The impact of the coronavirus disease 2019 (COVID-19) pandemic on methicillin-resistant Staphylococcus aureus (MRSA) bacteremia incidence compared with prepandemic trends is unknown. Methods: Active laboratory- and population-based surveillance identified incident MRSA blood isolates among surveillance area residents in 6 continuously reporting sites during 2005–2022. Annual incidence per 100 000 census population was stratified by epidemiologic classification (hospital-onset, community-associated, health care–associated community-onset). Joinpoint with Poisson regression was used to determine incidence trend segments and annual percent change (APC; 2005–2019) and predicted incidence (2020–2022). Recent COVID-19 was a positive severe acute respiratory syndrome coronavirus 2 viral test ≤30 days before incident MRSA culture. Results: Overall declines in MRSA bacteremia incidence during 2005–2016 (APC, –7.1; P < .001) reversed during 2016–2019 (APC, +5.9; P < .001). Hospital-onset incidence did not change significantly during 2014–2019 (APC, –1.5; P = .32), but during 2020–2022 it was higher than during 2016–2019 and significantly higher than predicted in 2021. Health care–associated community-onset incidence increased during 2017–2019 (APC, +8.4; P < .001); 2021 incidence was the lowest observed during 2005–2022, although it was not significantly lower than predicted. Community-associated incidence was increasing prepandemic (APC, +8.4; P < .001), but during 2020–2022 it was lower than predicted. During 2020–2022, the proportion of cases with recent COVID-19 was highest among hospital-onset infections (18%–22%); 2021 hospital-onset incidence excluding these cases fell within the predicted range. Conclusions: Previous declines in MRSA bacteremia incidence had ended before the COVID-19 pandemic. During 2020–2022, patients with recent COVID-19 contributed substantially to increases in hospital-onset MRSA bacteremia, suggesting a need for robust infection prevention in this population. Reversal of prepandemic increases in health care–associated community-onset and community-associated infections during the pandemic could be related to COVID-19 mitigation measures.

4 April 2017 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
HBHolly M. Biggs
Holly M. Biggs
MMMonica McNeal
Monica McNeal
WNW. Allan Nix
W. Allan Nix
CKCarolyn Kercsmar
Carolyn Kercsmar
ACAaron T. Curns
Aaron T. Curns
MSMary A. Staat
Mary A. Staat
Enterovirus D68 (EV-D68) caused a widespread outbreak of respiratory illness in the United States in 2014, predominantly affecting children. We describe EV-D68 rates, spectrum of illness, and risk factors from prospective, population-based acute respiratory illness (ARI) surveillance at a large US pediatric hospital. Children <13 years of age with ARI and residence in Hamilton County, Ohio were enrolled from the inpatient and emergency department (ED) settings at a children’s hospital in Cincinnati, Ohio, from 1 July to 31 October 2014. For each participant, we interviewed parents, reviewed medical records, and tested nasal and throat swabs for EV-D68 using real-time reverse- transcription polymerase chain reaction assay. EV-D68 infection was detected in 51 of 207 (25%) inpatients and 58 of 505 (11%) ED patients. Rates of EV-D68 hospitalization and ED visit were 1.3 (95% confidence interval [CI], 1.0–1.6) and 8.4 per 1000 children <13 years of age, respectively. Preexisting asthma was associated with EV-D68 infection (adjusted odds ratio, 3.2; 95% CI, 2.0–5.1). Compared with other ARI, children with EV-D68 were more likely to be admitted from the ED (P ≤ .001), receive supplemental oxygen (P = .001), and require intensive care unit admission (P = .04); however, mechanical ventilation was uncommon (2/51 inpatients; P = .64), and no deaths occurred. During the 2014 EV-D68 epidemic, high rates of pediatric hospitalizations and ED visits were observed. Children with asthma were at increased risk for medically attended EV-D68 illness. Preparedness planning for a high-activity EV-D68 season in the United States should take into account increased healthcare utilization, particularly among children with asthma, during the late summer and early fall.

17 June 2021 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
VCVictoria T Chu
Victoria T Chu
ESEsan Simon
Esan Simon
XLXiaoyan Lu
Xiaoyan Lu
PRPatrick Rockwell
Patrick Rockwell
GAGlen R Abedi
Glen R Abedi
HBHolly M Biggs
Holly M Biggs
Background: Although a human adenovirus (HAdV) vaccine is available for military use, officers-in-training are not routinely vaccinated. We describe an HAdV-associated respiratory outbreak among unvaccinated cadets at the US Coast Guard Academy and its impact on cadet training. Methods: We defined a case as a cadet with new onset cough or sore throat during August 1–October 4, 2019. We reviewed medical records and distributed a questionnaire to identify cases and to estimate impact on cadet training. We performed real-time polymerase chain reaction testing on patient and environmental samples and whole genome sequencing on a subset of positive patient samples. Results: Among the 1072 cadets, 378 (35%) cases were identified by medical records (n = 230) or additionally by the questionnaire (n = 148). Of the 230 cases identified from medical records, 138 (60%) were male and 226 (98%) had no underlying conditions. From questionnaire responses, 113 of 228 (50%) cases reported duty restrictions. Of cases with respiratory specimens, 36 of 50 (72%) were HAdV positive; all 14 sequenced specimens were HAdV-4a1. Sixteen (89%) of 18 environmental specimens from the cadet dormitory were HAdV-positive. Conclusions: The HAdV-4-associated outbreak infected a substantial number of cadets and significantly impacted cadet training. Routine vaccination could prevent HAdV respiratory outbreaks in this population.